{"title":"Single-shot multiparametric MRI for separating <i>T<sub>2</sub></i> effects from dynamic glucose-enhanced contrast.","authors":"Junxian Jin, Haizhen Ding, Zhekai Chen, Yuan Huang, Hongmin Chen, Zhong Chen, Lin Chen","doi":"10.7150/thno.116483","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> Glucose is a central substrate in cellular metabolism and serves as a non-invasive biomarker for pathological processes. Dynamic glucose-enhanced (DGE) MRI based on chemical exchange saturation transfer (CEST) offers a promising tool for mapping glucose uptake, but its quantification is confounded by glucose-induced changes in <i>T<sub>2</sub></i> relaxation in addition to glucose concentration. <b>Methods:</b> We developed a single-shot multiparametric CEST (MP-CEST) MRI sequence based on multi-echo spatiotemporal encoding (SPEN), enabling the simultaneous acquisition of <i>T<sub>2</sub></i> and saturation-weighted proton density (PD) maps within a single scan. To correct for <i>T<sub>2</sub></i> -related confounding effects in glucoCEST quantification, a two-step correction strategy was employed. First, the saturation-weighted PD maps, which mitigate <i>T<sub>2</sub></i> -dependent signal attenuation during image acquisition, were used to reconstruct the Z-spectrum, thereby providing a more accurate representation of the true saturation signal amplitude. Second, calibration curves derived from Bloch-McConnell simulations were applied in combination with the simultaneously acquired <i>T<sub>2</sub></i> maps to compensate for spillover effects in the Z-spectrum, thereby improving glucose-specific CEST contrast. The full framework was validated through phantom experiments and <i>in vivo</i> studies in rat brain and tumor xenograft models. Quantitative performance was evaluated by computing the Pearson correlation between DGE signals and <i>T<sub>2</sub></i> values before and after correction, as well as by comparing fitted <i>T<sub>2</sub></i> and PD values with reference maps. <b>Results:</b> Phantom experiments demonstrated high accuracy in PD and <i>T<sub>2</sub></i> quantification (R<sup>2</sup> > 0.99). <i>In vivo</i> studies in rat brain and tumor xenografts showed that the proposed correction method significantly reduced the correlation between DGE signals and <i>T<sub>2</sub></i> values, improving the specificity of glucose-related contrast. In addition, <i>T<sub>2</sub></i> maps provided complementary structural and physiological information relevant to tumor heterogeneity and tissue microstructure. <b>Conclusions:</b> The proposed MP-CEST approach improves the robustness and accuracy of DGE quantification, offering a more comprehensive metabolic imaging framework applicable to both oncological and neurological research.</p>","PeriodicalId":22932,"journal":{"name":"Theranostics","volume":"15 18","pages":"9678-9694"},"PeriodicalIF":13.3000,"publicationDate":"2025-08-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12486256/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Theranostics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.7150/thno.116483","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Glucose is a central substrate in cellular metabolism and serves as a non-invasive biomarker for pathological processes. Dynamic glucose-enhanced (DGE) MRI based on chemical exchange saturation transfer (CEST) offers a promising tool for mapping glucose uptake, but its quantification is confounded by glucose-induced changes in T2 relaxation in addition to glucose concentration. Methods: We developed a single-shot multiparametric CEST (MP-CEST) MRI sequence based on multi-echo spatiotemporal encoding (SPEN), enabling the simultaneous acquisition of T2 and saturation-weighted proton density (PD) maps within a single scan. To correct for T2 -related confounding effects in glucoCEST quantification, a two-step correction strategy was employed. First, the saturation-weighted PD maps, which mitigate T2 -dependent signal attenuation during image acquisition, were used to reconstruct the Z-spectrum, thereby providing a more accurate representation of the true saturation signal amplitude. Second, calibration curves derived from Bloch-McConnell simulations were applied in combination with the simultaneously acquired T2 maps to compensate for spillover effects in the Z-spectrum, thereby improving glucose-specific CEST contrast. The full framework was validated through phantom experiments and in vivo studies in rat brain and tumor xenograft models. Quantitative performance was evaluated by computing the Pearson correlation between DGE signals and T2 values before and after correction, as well as by comparing fitted T2 and PD values with reference maps. Results: Phantom experiments demonstrated high accuracy in PD and T2 quantification (R2 > 0.99). In vivo studies in rat brain and tumor xenografts showed that the proposed correction method significantly reduced the correlation between DGE signals and T2 values, improving the specificity of glucose-related contrast. In addition, T2 maps provided complementary structural and physiological information relevant to tumor heterogeneity and tissue microstructure. Conclusions: The proposed MP-CEST approach improves the robustness and accuracy of DGE quantification, offering a more comprehensive metabolic imaging framework applicable to both oncological and neurological research.
期刊介绍:
Theranostics serves as a pivotal platform for the exchange of clinical and scientific insights within the diagnostic and therapeutic molecular and nanomedicine community, along with allied professions engaged in integrating molecular imaging and therapy. As a multidisciplinary journal, Theranostics showcases innovative research articles spanning fields such as in vitro diagnostics and prognostics, in vivo molecular imaging, molecular therapeutics, image-guided therapy, biosensor technology, nanobiosensors, bioelectronics, system biology, translational medicine, point-of-care applications, and personalized medicine. Encouraging a broad spectrum of biomedical research with potential theranostic applications, the journal rigorously peer-reviews primary research, alongside publishing reviews, news, and commentary that aim to bridge the gap between the laboratory, clinic, and biotechnology industries.